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ABSTRACT: Studies on the origin of animal multi-
cellularity have increasingly focused on one of the closest
living relatives of animals, the choanoflagellate Salpingoeca
rosetta. Single cells of S. rosetta can develop into
multicellular rosette-shaped colonies through a process of
incomplete cytokinesis. Unexpectedly, the initiation of
rosette development requires bacterially produced small
molecules. Previously, our laboratories reported the planar
structure and femtomolar rosette-inducing activity of one
rosette-inducing small molecule, dubbed rosette-inducing
factor 1 (RIF-1), produced by the Gram-negative
Bacteroidetes bacterium Algoriphagus machipongonensis.
RIF-1 belongs to the small and poorly explored class of
sulfonolipids. Here, we report a modular total synthesis of
RIF-1 stereoisomers and structural analogs. Rosette-
induction assays using synthetic RIF-1 stereoisomers and
naturally occurring analogs defined the absolute stereo-
chemistry of RIF-1 and revealed a remarkably restrictive
set of structural requirements for inducing rosette
development.
Multicellularity, the transition from a unicellular to amulticellular organism, evolved at least 25 times within
eukaryotes, but it evolved only once in the animal lineage.1
Choanoflagellates, the closest living relatives of animals, have
emerged as important model organisms for reconstructing the
transition to multicellularity.2 Choanoflagellate cells have a
spherical to prolate spheroid cell body and an apical collar of
microvilli surrounding a single flagellum (Figure 1)3 that
resembles the feeding cells (choanocytes) of sponges.
Undulation of the apical flagellum generates water currents
that sweep bacteria against the microvillar collar, where they are
trapped and ultimately phagocytosed. One species of
choanoflagellate, Salpingoeca rosetta, exhibits both free-living
and multicellular colonial forms called rosettes; and this
transition provides the basis of our study (Figure 1).2
The rosette-shaped colonies formed by S. rosetta resemble
early stage morula embryos of diverse animals and develop
through a process of incomplete cytokinesis from a single
founding cell.4 The induction of rosette development requires a
bacterially produced signal from its prey Algoriphagus
machipongonensis.5 In a previous publication we identified the
planar structure of the first rosette-inducing factor (RIF-1, 1),
and we demonstrated its extraordinary femtomolar potency.6 In
this report, we describe a modular total synthesis that defines
the three-dimensional structure of RIF-1, the isolation of some
naturally occurring analogs, and a rosette-inducing assay to
establish initial structure−activity relations. In addition, we note
that synthetic RIF-1 by itself does not completely recapitulate
the activity of RIF-1 isolated from bacterial extract.
RIF-1 belongs to the small and poorly explored class of
sulfonolipids.7 Sulfonolipids have been reported as constituents
of the cell envelopes of Bacteroidetes bacteria and are thought
to contribute to the gliding motility frequently found in this
group.8 Sulfonolipids (2−4) closely resemble sphingolipids,
such as (dihydro)ceramides (Figure 2, 5), that are important
membrane components in eukaryotes and act as both structural
components and signaling molecules for cell death, survival,
differentiation, and migration.9 Sphingolipids and sulfonolipids
have been reported rarely in bacteria and so far have only been
isolated from the Bacteroidetes phylum and Sphingomonas
genus, where their biological functions are poorly understood.10
Both are amides of a fatty acid and an amine base called either
sphingosine (for sphingolipids) or capnine (for sulfonolipids).
Whereas sphingosine originates in the condensation of serine
with a fatty acid followed by reduction and dehydrogenation,
labeling studies with deuterated amino acids suggest that the
capnine base is biosynthesized via the condensation of a fatty
acyl-CoA with cysteic acid.11
To elucidate the stereochemistry of RIF-1 (Figure 2, 1), we
designed a flexible synthetic approach so that multiple
derivatives of RIF-1 could be produced without changing the
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Figure 1. Morphogenesis of the choanoflagellate S. rosetta upon
exposure to the prey bacterium A. machipongonensis: (A) unicellular
slow swimmer and (B) multicellular colonial rosette form (drawing:
courtesy of Mark Dayel).
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main synthetic route. The absolute stereochemistry of RIF-1
was unknown, but we assumed it to be homologous to reported
sulfonolipids (2−4).7,12 Therefore, we first focused on the two
completely unknown stereocenters at C-2′ and C-5, which
generates four possible diastereoisomeric targets.
The synthesis of the α-hydroxy fatty acid commenced with
the addition of cuprate reagent to benzyl-protected R(−) or
S(+)-glycidol (Scheme 1).13 After TBS protection, chain
elongation was pursued by metathesis reaction with a second
generation Hoveyda-Grubbs catalyst. A metathesis reaction at
this point allowed access to other fatty acid precursors with
different chain length and substitution pattern. The newly
generated double bond and the Bn-protecting group were
removed with Pd/C under hydrogen atmosphere in one step.
The primary alcohol was then treated with Dess-Martin reagent
and directly oxidized under standard reaction conditions with
NaClO2 in the presence of 2-methyl-2-butene yielding the
desired α-hydroxy fatty acid 8. The alternative fatty acid
precursor 10 could be obtained by addition of alkyne 9 to
glycidol ether 6, subsequent TBS protection of the secondary
alcohol, and reduction of the triple bond with PtO2. Alkynes
like 9 were synthesized according to literature procedures.14 To
assemble the sphingosine/capnine moiety, alkyne 12 was
treated with nBuLi and reacted with Garner’s aldehyde 11 in
the presence of HMPA to yield compound 13 in acceptable
75% (syn:anti 20:80) yield (Scheme 1).15 Over the course of
the synthesis, it became apparent that a late stage Mitsunobu
reaction for the introduction of the sulfonic acid group was a
more attractive synthetic approach than using a cysteine-
derived Garner’s aldehyde as described by Takikawa et al.12d
The next step involved a hydrosilylation reaction of 13 with
benzyldimethylsilane (BDMS-H) as reported by Trost.16 The
reaction proceeded with excellent regiocontrol (>95:5) and
afforded the desired silylated compound 14 in 90% yield.
Subsequent Tamao-Fleming oxidation using TBAF and H2O2
(2 h) yielded ketone 15. Gratifyingly, a one-pot procedure as
reported by Trost starting from compound 13 could be
accomplished affording ketone 15 in slightly higher overall yield
(82%). Finally, β-hydroxy ketone was stereoselectively reduced
using either Et2BOMe as chelating reagent to give almost
exclusively syn-diol 16 in 77% (dr, syn:anti > 90:10),17 or
Me4NB(OAc)3H to furnish anti-diol 17 with lower but
satisfactory diastereoselectivity.18 In addition, the alkyne moiety
of 13 was hydrogenated using PtO2 in nearly quantitative yield.
Since the stereochemistries of RIF-1’s hydroxy groups at C-2′
and C-5 were unknown, we first continued our synthetic
approach with α-hydroxy fatty acid 8 and syn-diol 16. The
cyclic isopropylaminal and Boc protecting groups were
removed in 6 N HCl at 60 °C yielding free sphingoid base
19, which was suitable for condensation with a fatty acid
(Scheme 2).
The sphingolipid core structure 20 was assembled by
treatment of 19 and fatty acid 8 with peptide coupling reagent
EDAC (Scheme 2). Subsequent protection with TBSOTf and
selective deprotection with TFA of the primary alcohol yielded
the key precursor for RIF-1. Finally, a Mitsunobu reaction of 20
with thioacetic acid, one-pot deprotection and oxidation of the
primary thiol with H2O2 afforded sulfonolipid 1 in an overall
yield of 8% (9 steps) starting from Garner’s aldehyde 11. The
spectroscopic data of 1 were in full agreement with the reported
Figure 2. (A) RIF-1 and known sulfonolipids; (B) retrosynthesis of
RIF-1.
Scheme 1. Representative Synthesis of (A) α-Hydroxy Acid
and (B) Precursor of Capnine Basea
aConditions: (a) Mg, CuI, THF, −20 °C, 84%; (b) TBSCl, TEA,
DMAP, DMF, quant.; (c) 5-methyl-1-hexene, 5 mol % Hoveyda-
Grubbs II catalyst, CH2Cl2, 40 °C, then; (d) Pd/C, H2, EtOAc:EtOH
1:1, 2 d, 79% over 2 steps; (e) DMP, 30 mol % NaHCO3, CH2Cl2, 0
°C → RT; then (f) NaClO2, 2-methyl-butene, THF:BuOH:H2O
(3:1:1), RT, 3 h, 65% over 2 steps; (g) nBuLi, HMPA, THF, −78 °C,
82%; (h) TBSCl, TEA, DMAP, DMF, quant.; (i) PtO2, H2, EtOAc, 1
d, quant.; (j) nBuLi, HMPA, THF, −78 °C, 75% (syn:anti 20:80); (k)
[Cp*Ru(NCCH3)3]
+PF6
−, BDMS-H, acetone, 0 °C → RT, 1 h, 90%;
(l) TBAF, THF, 15 min, 0 °C; then H2O2, MeOH, K2CO3, 12 h, RT,
87%; (m) Et2BOMe, NaBH4, THF:MeOH 4:1, 77% (syn:anti >
90:10); (n) Me4NB(OAc)3H, MeOH:AcOH, −40 °C, 91% (syn:anti
20:80); (o) PtO2, H2, EtOAc, 1 d, quant.
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data on natural RIF-1.6 For sulfonolipids 21−28 an analogous
synthetic route was performed.19
In a complementary approach we also investigated the
diversity of sulfonolipids produced by A. machipongonensis.5,6
The already reported sulfonolipids flavochristamide A and B (2,
3) were only detected in negligible amounts by LC-MS.
However, sulfobacin B (4) turned out to be one of the major
sulfonolipid products under our standard growth condition.19
By detailed analysis of the lipid extracts we were able to
isolate and characterize four unknown sulfonolipids 24, 29−31,
which we named accordingly (sulfobacins C−F, Figure 3A).
Synthetic compound 24, missing the C-5 hydroxy group, had
identical spectroscopic data as isolated sulfonolipid sulfobacin
D, suggesting the depicted absolute stereochemistry. These
synthetic and isolated materials allowed a preliminary
structure−activity analysis for rosette induction. All synthesized
(1, 21−28) and isolated sulfonolipids (1, 4, 24, 29−31) as well
as sphingolipid intermediates of type 20 were tested over a
broad concentration range (μM to fM) in a robust rosette
colony-induction assay with the S. rosetta RCA cell line.19 We
also tested the corresponding capnine bases (32−34), which
were obtained by hydrolysis with methanolic HCl. However,
RIF-1 diastereomers (21−23), RIF-1 analogs (24−31), and
capnine bases (32−34) did not induce rosette formation in S.
rosetta. Small amounts of isomers of sulfonolipids 24 and 31
were also tested, but they too showed no rosette-inducing
activity.19 Only synthetic and natural RIF-1 (1) stimulated the
development of solitary slow swimmers into rosette colonies.
This unexpectedly restricted set of structural requirements
indicates a highly specific substrate−receptor interaction.
Synthetic RIF-1 does not completely replicate the biological
activity of RIF-1 isolated from A. machipongonensis as shown by
quantitative comparison (Figure 3B). We are currently
exploring the reasons for this discrepancy by investigating
additional bacterially produced molecules with rosette-inducing
activity, molecules that synergize with RIF-1, and methods of
delivering these highly hydrophobic signals.
In summary, we have defined the three-dimensional structure
of RIF-1 through a modular total synthesis, characterized four
new naturally occurring sulfonolipids, established the tight
structural requirements for RIF-1’s biological activity, and
discovered that signals beyond RIF-1 may be needed for full
activity.
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Scheme 2. (A) Completion of the Total Synthesis and (B) Synthesis of Structurally Related Sulfonolipidsa
aConditions: (a) 6 N HCl, MeOH, 60 °C, 6 h; then (b) EDAC, compound 8, CH2Cl2, 2 h, 58% over 2 steps; (c) TBSOTf, 2,6-lutidine, DMAP,
CH2Cl2, 89%; (d) 10% TFA in H2O, THF, 0 °C→ RT, 6 h, 58% + 30% sm; (e) PPh3, DIAD, CH2Cl2, 1 h, 0 °C, then CH3COSH, 81%; (f) TFA,
H2O2, 4 h, RT, 65%.
Figure 3. (A) Isolated sulfonolipids from A. machipongonensis, and
corresponding capnine bases; and (B) dose−response curve of S.
rosetta (fM concentration range) after treatment with natural isolate
RIF-1 (black) and synthetic RIF-1 (red); error bars indicate standard
deviation.
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